Zobrazeno 1 - 10
of 239
pro vyhledávání: '"Murali, Gopalakrishnan"'
Autor:
Ulrich Koert, Philipp Reiß
Publikováno v:
Angewandte Chemie. 118:5540-5540
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6b9600ac14e12002d6aed908ad3e709
https://doi.org/10.1002/ange.200685419
https://doi.org/10.1002/ange.200685419
Autor:
Ulrich Koert, Philipp Reiß
Publikováno v:
Angewandte Chemie International Edition. 45:5414-5414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f70f1ca263198c9c652533b2a457a251
https://doi.org/10.1002/anie.200685419
https://doi.org/10.1002/anie.200685419
Autor:
Murali Gopalakrishnan
Publikováno v:
Asian Journal of Comparative Politics. 5:400-415
The acceptance of refugees and internally displaced persons represents the altruism of the countries of South Asia, which has witnessed the phenomenon of displaced persons since the early 19th century. The refugee phenomenon has a causal nature and w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89eaed1e8208f29f1aa9a25722417abb
https://doi.org/10.1177/2057891119881505
https://doi.org/10.1177/2057891119881505
Autor:
Arthur L. Nikkel, Marian T. Namovic, D. L. Widomski, Diana L. Donnelly-Roberts, Steve McGaraughty, Zhi Su, Laura Leys, Murali Gopalakrishnan
Publikováno v:
Journal of Basic and Clinical Physiology and Pharmacology. 29:281-290
Background:Losartan, a blocker of the angiotensin II type I receptor, is an important part of the standard of care for diabetic nephropathy (DN). The obese ZSF-1 rats display many aspects of the clinical features of human Type II DN. The current stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ee6718b0617d47fc87a9b5095eb0e3
https://doi.org/10.1515/jbcpp-2017-0157
https://doi.org/10.1515/jbcpp-2017-0157
Autor:
Anthony M. Giamis, Andrew Goodearl, Christine Grinnell, Kelly J. Doyle, Katherine Salte, Victor Sun, Todd B. Cole, Murali Gopalakrishnan, L. Olson, Susan E. Lacy, Meha Chhaya, Yanping Luo, Steve McGaraughty, Arthur L. Nikkel, Rachel Davis-Taber, Chang Z. Zhu, Gregory M. Preston
Publikováno v:
Journal of the American Society of Nephrology. 28:3616-3626
Targeted delivery of a therapeutic agent to a site of pathology to ameliorate disease while limiting exposure at undesired tissues is an aspirational treatment scenario. Targeting diseased kidneys for pharmacologic treatment has had limited success.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::659c791d91484f4775bf1a55608ce936
https://doi.org/10.1681/asn.2017010013
https://doi.org/10.1681/asn.2017010013
Autor:
Arthur L. Nikkel, Ji Ma, L. Olson, Sujatha M. Gopalakrishnan, Kelly J. Doyle, Vivek C. Abraham, D. L. Widomski, Steve McGaraughty, Brent Putman, Murali Gopalakrishnan, Laura Leys, Chang Z. Zhu, Steve D. Pratt, Zhi Su, Chih-Hung Lee, K. Salte
Publikováno v:
European Journal of Pharmacology. 788:1-11
Adenosine (ADO) is an important regulatory purine nucleoside that accumulates at sites of inflammation and tissue injury including in diseases associated with renal pathology. Endogenous levels of ADO may be increased by inhibiting the ADO-metabolizi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb16781e9a82796fc5637e8ffccc0b2
https://doi.org/10.1016/j.ejphar.2016.06.012
https://doi.org/10.1016/j.ejphar.2016.06.012
Autor:
Reiß, Philipp, Koert, Ulrich
Publikováno v:
Angewandte Chemie. International Edition; August 2006, Vol. 45 Issue: 33 p5414-5414, 1p
Autor:
Reiß, Philipp, Koert, Ulrich
Publikováno v:
Angewandte Chemie; August 2006, Vol. 118 Issue: 33 p5540-5540, 1p
Autor:
Diana L. Donnelly-Roberts, Arthur L. Nikkel, Chang Z. Zhu, Steve McGaraughty, Kelly J. Doyle, Murali Gopalakrishnan, Marian T. Namovic, K. Salte, Lauren Olsen, D. L. Widomski, Zhi Su
Publikováno v:
Journal of pharmacological and toxicological methods. 94(Pt 1)
Introduction The adenine model of kidney disease typically involves dietary delivery of adenine over several weeks. This model can be variable in its disease progression and can result in significant mortality. In the current study, the amount of ade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e16bcc1990a1673c0f52adad06e199e
https://pubmed.ncbi.nlm.nih.gov/29684554
https://pubmed.ncbi.nlm.nih.gov/29684554
Autor:
Steve, McGaraughty, Rachel A, Davis-Taber, Chang Z, Zhu, Todd B, Cole, Arthur L, Nikkel, Meha, Chhaya, Kelly J, Doyle, Lauren M, Olson, Gregory M, Preston, Christine M, Grinnell, Katherine M, Salte, Anthony M, Giamis, Yanping, Luo, Victor, Sun, Andrew D, Goodearl, Murali, Gopalakrishnan, Susan E, Lacy
Publikováno v:
Journal of the American Society of Nephrology : JASN. 28(12)
Targeted delivery of a therapeutic agent to a site of pathology to ameliorate disease while limiting exposure at undesired tissues is an aspirational treatment scenario. Targeting diseased kidneys for pharmacologic treatment has had limited success.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6aeb256d7adad1311bfdd617d18c9741
https://pubmed.ncbi.nlm.nih.gov/28827403
https://pubmed.ncbi.nlm.nih.gov/28827403